Affiliation: U.S. National Institutes of Health (NIH)

Dr. Joshua J. Todd is a Research Fellow and clinical trialist at the U.S. National Institutes of Health (NIH) Intramural Research Program (Tissue Injury Branch, National Institute of Nursing Research). He received his PhD in Biomedical Sciences from Ulster University in 2016 and completed his postdoctoral training at the NIH in 2019 where he worked on the first clinical trial for ryanodine receptor 1-related myopathies. Dr. Todd’s research is focused on developing small molecule and gene transfer-based therapeutic approaches for rare neurogenetic disorders of muscle with a particular focus on congenital myopathies and lysosomal storage disorders.